Publications in collaboration with researchers from Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (1)

2020

  1. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT

    Bone Marrow Transplantation